Answers are grounded in this paper and cite their sources.
Examining a large sample of acquisitions involving both listed (publicly traded) and unlisted (privately held firms or subsidiaries) lodging assets, this article reports that acquirers earn significant positive abnormal returns in both cases. However, these positive abnormal returns are primarily realized in deals involving unlisted targets. This remains true even after controlling for many deal and firm characteristics. Within the subset of acquisitions of unlisted targets, acquirer abnormal returns are significantly higher when relative size is greater, when at least some stock is tendered for the acquisition, and when the acquirer has not been active in acquisition in prior years.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: